Showing results (1821-1830 of 1,988) with videos related to
Sort By:
Pageof 199
Biomedicines|December 23, 2022
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH)Giulia Lamacchia, Lorenzo Salvati, Seble Tekle Kiros, et al.Retrovirology|February 24, 2021
Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spreadDaniel O Pinto, Sarah Al Sharif, Gifty Mensah, et al.Frontiers in Human Neuroscience|February 13, 2026
A cross-continental comparative analysis of the neurological manifestations of Long COVIDMillenia Jimenez, Melissa Lopez, Janet Miller, et al.Journal of Translational Medicine|November 6, 2015
Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosisRuben Magni, Benjamin H Espina, Ketul Shah, et al.Human Pathology|January 28, 1998
Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patientsM V Fleming, D G Guinee, W S Chu, et al.ACS Infectious Diseases|April 11, 2020
Accelerated Discovery of Potent Fusion Inhibitors for Respiratory Syncytial VirusNicole Pribut, Thomas M Kaiser, Robert J Wilson, et al.ACS Medicinal Chemistry Letters|May 26, 2018
Discovery of N-Alkyl Piperazine Side Chain Based CXCR4 Antagonists with Improved Drug-like PropertiesYesim A Tahirovic, Valarie M Truax, Robert J Wilson, et al.Chemsuschem|November 9, 2013
Design, synthesis, and evaluation of nonaqueous silylamines for efficient CO2 captureJackson R Switzer, Amy L Ethier, Emily C Hart, et al.Plos One|April 28, 2010
Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survivalVirginia Espina, Brian D Mariani, Rosa I Gallagher, et al.Plos Pathogens|August 15, 2024
Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition propertiesZheng Zhou, Jia Guo, Brian Hetrick, et al.Pageof 199